1 |
Chandra J, Samali A, Orrenius S. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 29: 323-333, 2000
DOI
ScienceOn
|
2 |
Constantini PC, Chernyak BC, Petronilli V, Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J Biol Chem 271: 6746-6751, 1996
DOI
|
3 |
Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341: 233-249, 1999
DOI
ScienceOn
|
4 |
Fonck C, Baudry M. Toxic effects of $MPP^+$ and MPTP in PC12 cells independent of reactive oxygen species formation. Brain Res 905: 199-206, 2001
DOI
|
5 |
Lee CS, Park SY, Ko HH, Song JH, Shin YK, Han ES. Inhibition of $MPP^+$-induced mitochondrial damage and cell death by rifluoperazine and W-7 in PC12 cells. Neurochem Int 46; 169-178, 2005
DOI
ScienceOn
|
6 |
Lotharius J, Dugan LL, O'Malley KL. Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons. J Neurosci 19: 1284-1293, 1999
DOI
|
7 |
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983
DOI
|
8 |
Obata T. Dopamine efflux by MPTP and hydroxyl radical generation. J Neural Transm 109: 1159-1180, 2002
DOI
|
9 |
Vaglini F, Pardini C, Cavalletti M, Maggio R, Corsini GU. L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion. Brain Res 741: 68-74, 1996
DOI
|
10 |
Le W, Jankovic J, Xie W, Kong R, Appel SH. (-)-Deprenyl protection of 1-methyl-4-phenylpyridium ion ($MPP^+$)-induced apoptosis independent of MAO-B inhibition. Neurosci Lett 224: 197-200, 1997
DOI
ScienceOn
|
11 |
Tatton WG, Chalmers-Redman RME, Tatton NA. Neuroprotection by deprenyl and other propargylamines: glyceraldehydes-3-phosphate dehydrogenase rather than monoamine oxidase B. J Neural Transm 110: 509-515, 2003
DOI
|
12 |
Fu W, Luo H, Parthasarathy S, Mattson MP. Catecholamines potentiate amyloid -peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis. Neurobiol Dis 5: 229-243, 1998
DOI
ScienceOn
|
13 |
Andoh T, Chock PB, Murphy DL, Chiueh CC. Role of the redox protein thioredox in cytoprotective mechanism evoked by (-)-deprenyl. Mol Pharmacol 68: 1408-1414, 2005
DOI
ScienceOn
|
14 |
Birkmayer W, Knoll J, Riederer P, Youdim MB, Hars V, Marton J. Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study. J Neural Transm 64: 113-127, 1985
DOI
|
15 |
Tatton WG, Chalmers-Redman RME, Ju WJH. Mammen M, Carlile GW, Pong AW, Tatton NA. Propargylamines induce antiapoptotic new protein synthesis in serum- and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J Pharmacol Exp Ther 301: 753-764, 2002
DOI
ScienceOn
|
16 |
Maher P, Davis JB. The role of monoamine metabolism in oxidative glutamate toxicity. Neuroscience 16: 6394-6401, 1996
DOI
|
17 |
Crow MT, Mani K, Nam Y-J, Kitsis RN. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ Res 95: 957-970, 2004
DOI
ScienceOn
|
18 |
Kim R, Emi M, Tanabe K. Role of mitochondria as the gardens of cell death. Cancer Chemother Pharmacol 57: 545-553, 2006
DOI
ScienceOn
|
19 |
Lee CS, Han JH, Jang YY, Song JH, Han ES. Differential effect of catecholamines and $MPP^+$ on membrane permeability in brain mitochondria and cell viability in PC12 cells. Neurochem Int 40: 361-369, 2002
DOI
ScienceOn
|
20 |
van Klaveren RJ, Hoet PH, Pype JL, Demedts M, Nemery B. Increase in gamma-glutamyltransferase by glutathione depletion in rat type II pneumocytes. Free Radic Biol Med 22: 525-534, 1997
DOI
ScienceOn
|
21 |
Rojas P, Rios C. Increased striatal lipid peroxidation after intracerebroventricular $MPP^+$ administration to mice. Pharamcol Toxicol 72: 364-368, 1993
DOI
ScienceOn
|
22 |
Tan S, Sagara Y, Liu Y, Maher P, Schubert D. The regulation of reactive oxygen species production during programmed cell death. J Cell Biol 141: 1423-1432, 1998
DOI
ScienceOn
|
23 |
Yi H, Akao Y, Maruyama W, Chen K, Shih J, Naoi M. Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis to apoptosis in SH-SY5Y cells. J Neurochem 96: 541-549, 2006
DOI
ScienceOn
|
24 |
Tatton WG, Chalmers-Redman RME. Modulation of gene expression rather than monoamine oxidase inhibition. Neurology 47(Suppl. 3): S171-S183, 1996
DOI
|
25 |
Lai C-T, Yu PH. Dopamine- and L- -3,4-dihydroxyphenylalanine hydrochloride (L-DOPA)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors. Biochem Pharmacol 53: 363-372, 1997
DOI
ScienceOn
|
26 |
Cassarino DS, Parks JK, Parker Jr WD, Bennett Jr JP. The Parkinsonian neurotoxin $MPP^+$ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim Biophys Acta 1453: 49-62, 1999
DOI
ScienceOn
|
27 |
Marcocci L, De Marchi U, Salvi M, Milella ZG, Nocera S, Agostinelli E, Mondovi B, Toninello A. Tyramine and monoamine oxidase inhibitors as modulators of the mitochondrial membrane permeability transition. J Membr Biol 188: 23-31, 2002
DOI
ScienceOn
|
28 |
Kadota T, Yamaai T, Saito Y, Akita Y, Kawashima S, Moroi K, Inagaki N, Kadota K. Expression of dopamine transporter at the tips of growing neurites of PC12 cells. J Histochem Cytochem 44: 989-996, 1996
DOI
ScienceOn
|
29 |
Wu RM, Chen RC, Chiueh CC. Effect of MAO-B inhibitors on $MPP^+$ toxicity in Vivo. Ann NY Acad Sci 899: 255-261, 2000
DOI
|
30 |
Lee CS, Han ES, Jang YY, Han JH, Ha HW, Kim DE. Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 Cells. J Neurochem 75: 521-531, 2000
DOI
ScienceOn
|
31 |
Hall AG. The role of glutathione in the regulation of apoptosis. Eur J Clin Invest 29: 238-245, 1999
DOI
ScienceOn
|